Chemotherapy versus chemotherapy plus radiotherapy in the treatment of tonsillar squamous cell carcinoma in the dog.
The effect of adjuvant chemotherapy and combined chemotherapy and radiotherapy in 22 dogs with advanced canine tonsillar carcinoma (World Health Organization [WHO], T2-3 primary tumor with infiltration into surrounding tissues) was evaluated. There were four treatment groups of at least five dogs each. Combinations of chemotherapeutic drugs reported to have activity against squamous cell carcinoma in humans and dogs (doxorubicin, cisplatin, vinblastine, and cyclophosphamide) were administered after tonsillectomy. Radiation therapy (orthovoltage type, external beam) was combined with chemotherapy in one treatment group. The dogs that had combination radiation therapy and chemotherapy had higher response rates and significantly longer survival times. However, most dogs died of progression of disease.
Brooks
M B
MB
Donaldson-Atwood Cancer Clinic, Animal Medical Center, New York, NY 10021.
Matus
R E
RE
Leifer
C E
CE
Alfieri
A A
AA
Patnaik
A K
AK
D000818:Animals; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy / Q000532:radiotherapy / Q000662:veterinary*; D002945:Cisplatin / Q000008:administration & dosage; D003131:Combined Modality Therapy / Q000662:veterinary; D003520:Cyclophosphamide / Q000008:administration & dosage; D004283:Dog Diseases / Q000188:drug therapy / Q000532:radiotherapy / Q000628:therapy*; D004285:Dogs; D004317:Doxorubicin / Q000008:administration & dosage; D005260:Female; D008297:Male; D012189:Retrospective Studies; D013997:Time Factors; D014067:Tonsillar Neoplasms / Q000188:drug therapy / Q000532:radiotherapy / Q000628:therapy* / Q000662:veterinary*; D014747:Vinblastine / Q000008:administration & dosage
D014747:Vinblastine; D004317:Doxorubicin; D003520:Cyclophosphamide; D002945:Cisplatin